Nestle Health Science buys Prometheus; Integra acquires SeaSpine;

> Prometheus Laboratories, a specialty pharmaceutical and diagnostic company, has entered into a definitive agreement to be acquired by Nestlé Health Science, a wholly-owned subsidiary of Nestlé, for an undisclosed amount. Prometheus release

> Integra LifeSciences Holdings has acquired SeaSpine, which provides products for the spine fusion market, for $89 million in cash, subject to certain post-closing adjustments. After the combination, the spine and orthobiologics portfolio is now the largest component of Integra's Orthopedics revenue category. Integra release

> Abbott has received FDA approval for the XIENCE nano Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease in small vessels. Abbott release

> ResMed has released the ResMed Sleep Assessment app, a novel new app for iPhone that lets users record themselves during sleep. The app also includes a clinically validated questionnaire that assesses their risk and other helpful features to empower users to discuss their sleep health with their physician. Resmed release

> Medical device jobs will be "washing back on U.S. shores" from overseas over the next decade due to security and privacy issues, according to a report. And this may be good news for the Twin Cities, which the report by consulting firm The Boyd Co. Inc. said is "the epicenter of the U.S. medical devices and supplies industry." Story

> Dealing with infection is a complex problem facing orthopedic surgeons, and a growing concern as the first of the baby boomer generation turns 65--increasing the number of artificial hips, knees and other orthopedic devices implanted in patients. Report

And Finally... 2011 Invention Awards: A Better Mechanical Hand. PopSci looks at a prosthetic hand that's as functional as an electronic model-but at a fraction of the cost. News

Suggested Articles

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.